PureTech Health plc
Status: Publicly traded
Direct answer
PureTech Health plc is publicly traded on LSE under the ticker PRTC.L.
PureTech Health Plc engages in the provision of differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders. It operates through the following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Company and...
Can you invest in PureTech Health plc?
Yes. PureTech Health plc trades publicly on LSE as PRTC.L.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for PureTech Health plc
Detailed equity research is provided by MarketSnap.